课题基金 / 基金详情

QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE

QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE
定量病毒生长检测 (QVOA) 服务资源
批准号:
9149484
负责人:
MICHAEL MURRAY
金额:
$159.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2016-06-30

项目摘要

项目成果

MICHAEL MURRAY的其他基金

相似基金

相关文献

中文摘要
翻译
使用高效抗逆转录病毒疗法(HAART)可以有效地抑制HIV感染患者的HIV-1复制。然而,尽管有效的抑制治疗,HIV已知存在于潜伏期状态,最具特征的潜伏库是静止的记忆CD4T细胞。当这些休眠细胞在细胞激活后其休眠状态发生逆转时,就会产生艾滋病毒。为了实现艾滋病毒疾病的治愈,需要识别和消除艾滋病毒的潜在蓄水池。为了评估这些策略在清除潜伏病毒库方面的有效性,能够量化潜伏艾滋病毒的可重复性检测是至关重要的。当今最具特色的检测方法是QVOA(定量病毒生长分析),也被称为IUPM(感染单位/百万),在逆转潜伏期和诱导HIV复制的条件下对高纯度的静止CD4T细胞进行检测。然而,QVOA测量需要大量的血液,昂贵、繁琐和劳动密集型,因此不是许多进行艾滋病毒根除研究的实验室的选择。NIAID要求将QVOA作为一项服务提供给艾滋病毒研究界。这项服务将允许标准化的QVOA测量,以便能够在不同根除策略之间进行公正的比较。该检测方法的广泛使用将提高潜伏性艾滋病毒检测的标准,并减少对一些实验室目前使用的不太准确的替代检测方法的需求。
英文摘要
HIV-1 replication can be effectively suppressed in HIV infected patients using highly active antiretroviral therapy (HAART). However, despite effective suppressive therapy, HIV has been known to exist in a state of latency, with the best characterized latent reservoir being the resting memory CD4+ T cells. These resting cells produce HIV when their resting state is reversed following cellular activation. To achieve a cure for HIV disease, the latent reservoir of HIV needs to be identified and eliminated. In order to evaluate the effectiveness of these strategies at clearing the latent reservoir, a reproducible assay capable of quantifying latent HIV is crucial. The best characterized assay today is the QVOA (Quantitative Viral Outgrowth Assay), also known as IUPM assay (Infectious Units Per Million) performed on highly purified resting CD4+ T cells under conditions that reverse latency and induce replication of HIV. However, QVOA measurements require large volumes of blood, are expensive, tedious, and labor intensive and therefore not the assay of choice for many laboratories conducting HIV eradication research. NIAID has a requirement to provide the QVOA as a service to the HIV research community. This service will allow standardized QVOA measurements so that unbiased comparisons between different eradication strategies can be achieved. Widespread use of the assay will raise the standards for latent HIV detection and reduce the need for surrogate, less accurate assays, presently used by some laboratories.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task B18: Ebolavirus Screens
  • 批准号:
    9148147
  • 项目类别:
  • 资助金额:
    $0.78万
  • 财政年份:
    2014
  • 负责人:
    MICHAEL MURRAY
  • 依托单位:
Task A60: Mouse Models for Polio and Coxsackie Viruses
  • 批准号:
    9430033
  • 项目类别:
  • 资助金额:
    $35.64万
  • 财政年份:
    2014
  • 负责人:
    MICHAEL MURRAY
  • 依托单位:
Task A60: Mouse Models for Polio and Coxsackie Viruses
  • 批准号:
    8930770
  • 项目类别:
  • 资助金额:
    $82.31万
  • 财政年份:
    2010
  • 负责人:
    MICHAEL MURRAY
  • 依托单位:
IN VITRO ANTIVIRAL SCREENING PROGRAM-HEPATITIS C & B VIRUS
  • 批准号:
    7543732
  • 项目类别:
  • 资助金额:
    $245.99万
  • 财政年份:
    2003
  • 负责人:
    MICHAEL MURRAY
  • 依托单位:
    --
海外基金